Societal cost of skin cancer in Sweden in 2005

Acta Dermato-Venereologica

Volumn 88, Issue 5, 2008, Pages 467-473

  Tinghög, Gustav ^a   Carlsson, Per ^a   Synnerstand, Ingrid ^a   Rosdahl, Inger ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cost; Cost of illness; Skin cancer; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MORBIDITY; OUTPATIENT CARE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SKIN CANCER; SWEDEN;

ADULT; AMBULATORY CARE; COST OF ILLNESS; EFFICIENCY, ORGANIZATIONAL; FEMALE; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PRIMARY HEALTH CARE; REGISTRIES; SKIN NEOPLASMS; SWEDEN;

EID: 53349097913     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0523     Document Type: Article

References (35)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-185.
2. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146: 1-6.
3. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation, N Engl J Med 1999; 340: 1341-1348.
4. Perlis C, Herlyn M. Recent advances in melanoma biology. Oncologist 2004; 9: 182-187.
5. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029-1031.
6. Roenigk RK, Ratz, JL, Bailin PL, Wheeland RG. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 1986; 12: 860-865.
7. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992; 327: 1649-1662.
8. Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultra-violet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 1999; 28: 418-427.
9. Centre for Epidemiology. Cancer incidence in Sweden 2005. Health Diseases 2007: 3.
10. The National Board of Health and Welfare. Basalcellscancer -Statistik för 2004-2005. [Basal cell cancer. Statistics for 2004-2005.] Stockholm: The National Board of Health and Welfare, 2006 (in Swedish).
11. The National Board of Health and Welfare. Causes of death 2003. Official statistics of Sweden 2005: 7. Stockholm: The National Board of Health and Welfare, 2005.
12. Statistics Sweden. Vägtrafikskador. SIKA statistik 2006: 3.
13. Rice DP, editor. Estimating the cost of illness. Health economics series no. 6 Washington: Public Health Service, Division of Medical Care Administration, 1966.
14. World Health Organization. International statistical classification of diseases and related health problems: ICD-10. 2nd edn. Geneva: World Health Organization, 2004.
15. The National Board of Health and Welfare. Statistical databases - cancer statistics, 2007. [cited 2007 Nov 20] Available from URL: http://www.socialstyrelsen.se/Statistik/statistikdatabas/
16. Centre for Epidemiology. Patientregistret - Utskrivningar från sluten vård 1964-2005 kvalitet och innehåll. [Discharges from in-patient care 1964-2005. Quality and content.] Stockholm: The National Board of Health and Welfare, 2006 (in Swedish).
17. The Swedish Association of Local Authorities and Regions. Nationella KPP-principer: Kostnad Per Patient: en rapport från arbetet med patientrelaterad redovisning (KPP och DRG) vid Sveriges kommuner och landsting. 1.1 ed. [Cost per patient. A report from the work with patient-related accounts.] Stockholm: Sveriges kommuner och landsting, 2006 (in Swedish).
18. Augustsson A, Stierner U, Suurkula M, Rosdahl I. Prevalence of common and dysplastic naevi in a Swedish population. Br J Dermatol 1991; 124: 152-156.
19. The Swedish Association of Local Authorities and Regions, KPP i primärvården: resultat från ett pilotprojekt: en rapport från Landstingsförbundets KPP-arbete. [Cost per patient in primary care, results from a pilot study.] Stockholm: Landstingsförb, 2003 (in Swedish).
20. Wiréhn A-B. A data-rich world: population-based registers in healthcare research. Linköping, Department of Medicine and Health Sciences Linköping University, 2007.
21. Weisbrod B. The valuation of human capital. J Political Econ 1961; 69: 425-436.
22. Statistics Sweden. Total income from employment and business 2005. [cited 2007 Dec 151. Available from URL: http://www.scb.se/templates/ tableOrChart_118429.asp
23. Statistics Sweden. Statistical yearbook Sweden 2005. Stockholm: Statistiska. centralbyrån, 2005.
24. Swedish Pharmaceuticals Benefit Board. General guidelines on economic evaluations. LFNAR 2003: 2, 2003. Stockholm Swedish Pharmaceuticals Benefit Board, 2003.
25. Gold MR, editor. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
26. Nilsson GH, Carlsson L, Dal H, Ullen H. Skin diseases caused by ultraviolet radiation: the cost of illness. Int J Technol Assess Health Care 2003; 19: 724-730.
27. Lidgren M, editor. Health economics of breast cancer. Stockholm, 2007.
28. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006; 9: 87-98.
29. Terent A, Marke LA, Asplund K, Norrving B, Jonsson E, Wester PO. Costs of stroke in Sweden. A national perspective. Stroke 1994; 25: 2363-2369.
30. Henriksson F, Jonsson B. Diabetes: the cost of illness in Sweden. J Intern Med 1998; 244: 461-468.
31. Lidgren M, Wilking N, Jonsson B. Cost of breast cancer in Sweden in 2002. Eur J Health Econ 2007; 8: 5-15.
32. Henriksson F, Jonsson B. The economic cost of multiple sclerosis in Sweden in 1994. Pharmacoeconomics 1998; 13: 597-606.
33. Blomqvist P, Lycke J, Strang P, Tornqvist H, Ekbom A. Brain tumours in Sweden 1996: care and costs. J Neurol Neurosurg Psychiatry 2000; 69: 792-798.
34. Carter R, Marks R, Hill D. Could a national skin cancer primary prevention campaign in Australia be worthwhile? An economic perspective. Health Promotion International 1999; 14: 73-82.
35. Losina E, Walensky RP, Geller A, Beddingfield FC 3rd, Wolf LL, Gilchrest BA, Freedberg KA. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol 2007; 143: 21-28.